Your Solution for more Efficiency and Accuracy
The Fully Automated LabDisk-Analyzer
Dermatology faces unique challenges in accurately diagnosing similar-looking conditions like psoriasis and eczema. Up to 50% of cases face diagnostic uncertainty1,2 , making treatment decisions challenging and leading to potential delays in patient care.
The LabDisk-Analyzer by Dermagnostix addresses these pain points directly by introducing an objective, microfluidics-based approach to dermatology diagnostics.

Its plug-and-play setup minimizes the need for extensive staff training and reduces dependency on disposable lab materials, leading to cost savings. By combining innovation with reliability, the LabDisk-Analyzer is setting new standards in dermatology, ensuring patients receive the targeted care they need, while laboratories gain a competitive advantage in accuracy and efficiency.
The fully automated Dermagnostix system includes the LabDisk, which integrates advanced molecular testing into a compact, easy-to-use format that supports diagnostic accuracy.
The test results are stored in the Dermagnostix cloud-based software, where you benefit from fast customer support and over-the-air software updates. These features enable quick generation of diagnostic reports through simple copy and paste. With the system's high precision, dermatologists and dermatopathologists gain a reproducible and standardized method for differential diagnosis of complex skin diseases, enhancing their confidence in results.
Setting New Standards in Dermatological Diagnostics
Your Benefits at a Glance



More Dermagnostix Products
PsorX-LabDisk
The PsorX-LabDisk, in combination with the LabDisk-Analyzer, delivers unparalleled accuracy and speed for dermatology diagnostics. This molecular test for differentiating psoriasis and eczema empowers dermatopathologists with precise gene expression-based insights in just two hours. Together with the LabDisk-Analyzer, it creates a fully automated, user-friendly diagnostic platform designed to minimize uncertainty and support clinical workflows.
Pipeline Products
Explore our innovative upcoming products transforming molecular diagnostics for dermatology: PsorX 2.0 for the differential diagnosis of psoriasis, eczema and tinea using non-invasive sampling for the use at the point-of-care. LymphX for the differential diagnosis of mycosis fungoides, psoriasis, and eczema, enabling earlier and more accurate diagnosis. And PatternX to support clinicans with biomarker characterization and stratification of patients according to moelcular patterns.
Shaping the Future of Dermatology Together!
